[Maximal oxygen consumption measured in the cardiopulmonary stress test versus the predicted maximal consumption: an evaluation of 3 protocols].
Trabulo
M
M
Serviço de Cardiologia, Hospital de Santa Cruz.
Bronze
L
L
Brízida
L
L
Barbaça
A
A
Mendes
M
M
Seabra-Gomes
R
R
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000375:Aging / Q000502:physiology; D001022:Aortic Valve Insufficiency / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D002985:Clinical Protocols; D003327:Coronary Disease / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D005069:Evaluation Studies as Topic; D005080:Exercise Test / Q000187:drug effects / Q000379:methods* / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000187:drug effects
D000319:Adrenergic beta-Antagonists
Consumo máximo de oxigénio medido em prova de esforço cardiopulmonar versus consumo máximo previsto: avaliação de três protocolos.